Actively controlled local drug delivery using conductive polymer-based devices

Localized and actively controlled delivery of drugs presents an opportunity for improving bioavailability, therapeutic efficacy, and long-term treatment of injury or disease. Conductive polymer (CP) based systems present a unique opportunity for using inherent electrochemical and actuating propertie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Applied physics letters 2020-01, Vol.116 (1)
Hauptverfasser: Chapman, Christopher A. R., Cuttaz, Estelle A., Goding, Josef A., Green, Rylie A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page
container_title Applied physics letters
container_volume 116
creator Chapman, Christopher A. R.
Cuttaz, Estelle A.
Goding, Josef A.
Green, Rylie A.
description Localized and actively controlled delivery of drugs presents an opportunity for improving bioavailability, therapeutic efficacy, and long-term treatment of injury or disease. Conductive polymer (CP) based systems present a unique opportunity for using inherent electrochemical and actuating properties to ensure that drugs are delivered or retained using charge controlled mechanisms. A number of CP formats have been explored spanning CP films, composites of CPs with polymeric carriers, and organic electronic ion pumps (OEIPs). Each of these designs can be used to deliver drugs with ionic properties that take advantage of the doping and dedoping characteristics of CPs during electrical pulsing or cycling. However, CP composites that use actuation and OEIPs are emerging technologies that can better address the need for the delivery of a wide range of drugs with varying net charge properties. These systems also allow a high drug loading profile, and with an appropriate configuration, they can use additional electrodes to drive drugs into the tissues. There are also innovative opportunities in the delivery of multiple drug types with varying charge properties that can be individually addressed. The future of CP based drug delivery systems will be strongly influenced by translational challenges including the need for regulatory approvals prior to the use of these novel material platforms in the clinic. Multidisciplinary collaboration will be critical to driving technology development and creating a new paradigm in personalized bioelectronic delivery of therapeutics.
doi_str_mv 10.1063/1.5138587
format Article
fullrecord <record><control><sourceid>proquest_scita</sourceid><recordid>TN_cdi_scitation_primary_10_1063_1_5138587</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2332209286</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-87ee1938bf7b26373bb0ccc81bc2107cca6fb3eb5ae5401bc05f6b405852ebd3</originalsourceid><addsrcrecordid>eNp9kEtLw0AQxxdRsFYPfoOAJ4XUfXST7bEUX1D00vuyj0lJ2WbjbhLIt3drix4ET8PM_P7_eSB0S_CM4II9khknTHBRnqEJwWWZM0LEOZpgjFleLDi5RFcx7lLKKWMT9L40XT2AGzPjmy5458BmzhvlMhv6bWbBpXYYsz7WzfYA2f5bkbXejXsIuVYxSSwMtYF4jS4q5SLcnOIUbZ6fNqvXfP3x8rZarnPDCtrlogQgCyZ0VWpasJJpjY0xgmhD09bGqKLSDDRXwOc4VTGvCj3HXHAK2rIpujvatsF_9hA7ufN9aNJEma6iFC-oKBJ1f6RM8DEGqGQb6r0KoyRYHr4liTx9K7EPRzaaulNd7ZsfePDhF5Strf6D_zp_AX5LeXU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2332209286</pqid></control><display><type>article</type><title>Actively controlled local drug delivery using conductive polymer-based devices</title><source>American Institute of Physics (AIP) Journals</source><source>Alma/SFX Local Collection</source><creator>Chapman, Christopher A. R. ; Cuttaz, Estelle A. ; Goding, Josef A. ; Green, Rylie A.</creator><creatorcontrib>Chapman, Christopher A. R. ; Cuttaz, Estelle A. ; Goding, Josef A. ; Green, Rylie A.</creatorcontrib><description>Localized and actively controlled delivery of drugs presents an opportunity for improving bioavailability, therapeutic efficacy, and long-term treatment of injury or disease. Conductive polymer (CP) based systems present a unique opportunity for using inherent electrochemical and actuating properties to ensure that drugs are delivered or retained using charge controlled mechanisms. A number of CP formats have been explored spanning CP films, composites of CPs with polymeric carriers, and organic electronic ion pumps (OEIPs). Each of these designs can be used to deliver drugs with ionic properties that take advantage of the doping and dedoping characteristics of CPs during electrical pulsing or cycling. However, CP composites that use actuation and OEIPs are emerging technologies that can better address the need for the delivery of a wide range of drugs with varying net charge properties. These systems also allow a high drug loading profile, and with an appropriate configuration, they can use additional electrodes to drive drugs into the tissues. There are also innovative opportunities in the delivery of multiple drug types with varying charge properties that can be individually addressed. The future of CP based drug delivery systems will be strongly influenced by translational challenges including the need for regulatory approvals prior to the use of these novel material platforms in the clinic. Multidisciplinary collaboration will be critical to driving technology development and creating a new paradigm in personalized bioelectronic delivery of therapeutics.</description><identifier>ISSN: 0003-6951</identifier><identifier>EISSN: 1077-3118</identifier><identifier>DOI: 10.1063/1.5138587</identifier><identifier>CODEN: APPLAB</identifier><language>eng</language><publisher>Melville: American Institute of Physics</publisher><subject>Actuation ; Applied physics ; Bioavailability ; Bioelectricity ; Composite materials ; Conducting polymers ; Drug delivery systems ; Drugs ; Ion pumps ; New technology ; Properties (attributes)</subject><ispartof>Applied physics letters, 2020-01, Vol.116 (1)</ispartof><rights>Author(s)</rights><rights>2020 Author(s). Published under license by AIP Publishing.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-87ee1938bf7b26373bb0ccc81bc2107cca6fb3eb5ae5401bc05f6b405852ebd3</citedby><cites>FETCH-LOGICAL-c362t-87ee1938bf7b26373bb0ccc81bc2107cca6fb3eb5ae5401bc05f6b405852ebd3</cites><orcidid>0000-0003-1569-7288</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://pubs.aip.org/apl/article-lookup/doi/10.1063/1.5138587$$EHTML$$P50$$Gscitation$$H</linktohtml><link.rule.ids>314,776,780,790,4498,27901,27902,76127</link.rule.ids></links><search><creatorcontrib>Chapman, Christopher A. R.</creatorcontrib><creatorcontrib>Cuttaz, Estelle A.</creatorcontrib><creatorcontrib>Goding, Josef A.</creatorcontrib><creatorcontrib>Green, Rylie A.</creatorcontrib><title>Actively controlled local drug delivery using conductive polymer-based devices</title><title>Applied physics letters</title><description>Localized and actively controlled delivery of drugs presents an opportunity for improving bioavailability, therapeutic efficacy, and long-term treatment of injury or disease. Conductive polymer (CP) based systems present a unique opportunity for using inherent electrochemical and actuating properties to ensure that drugs are delivered or retained using charge controlled mechanisms. A number of CP formats have been explored spanning CP films, composites of CPs with polymeric carriers, and organic electronic ion pumps (OEIPs). Each of these designs can be used to deliver drugs with ionic properties that take advantage of the doping and dedoping characteristics of CPs during electrical pulsing or cycling. However, CP composites that use actuation and OEIPs are emerging technologies that can better address the need for the delivery of a wide range of drugs with varying net charge properties. These systems also allow a high drug loading profile, and with an appropriate configuration, they can use additional electrodes to drive drugs into the tissues. There are also innovative opportunities in the delivery of multiple drug types with varying charge properties that can be individually addressed. The future of CP based drug delivery systems will be strongly influenced by translational challenges including the need for regulatory approvals prior to the use of these novel material platforms in the clinic. Multidisciplinary collaboration will be critical to driving technology development and creating a new paradigm in personalized bioelectronic delivery of therapeutics.</description><subject>Actuation</subject><subject>Applied physics</subject><subject>Bioavailability</subject><subject>Bioelectricity</subject><subject>Composite materials</subject><subject>Conducting polymers</subject><subject>Drug delivery systems</subject><subject>Drugs</subject><subject>Ion pumps</subject><subject>New technology</subject><subject>Properties (attributes)</subject><issn>0003-6951</issn><issn>1077-3118</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLw0AQxxdRsFYPfoOAJ4XUfXST7bEUX1D00vuyj0lJ2WbjbhLIt3drix4ET8PM_P7_eSB0S_CM4II9khknTHBRnqEJwWWZM0LEOZpgjFleLDi5RFcx7lLKKWMT9L40XT2AGzPjmy5458BmzhvlMhv6bWbBpXYYsz7WzfYA2f5bkbXejXsIuVYxSSwMtYF4jS4q5SLcnOIUbZ6fNqvXfP3x8rZarnPDCtrlogQgCyZ0VWpasJJpjY0xgmhD09bGqKLSDDRXwOc4VTGvCj3HXHAK2rIpujvatsF_9hA7ufN9aNJEma6iFC-oKBJ1f6RM8DEGqGQb6r0KoyRYHr4liTx9K7EPRzaaulNd7ZsfePDhF5Strf6D_zp_AX5LeXU</recordid><startdate>20200106</startdate><enddate>20200106</enddate><creator>Chapman, Christopher A. R.</creator><creator>Cuttaz, Estelle A.</creator><creator>Goding, Josef A.</creator><creator>Green, Rylie A.</creator><general>American Institute of Physics</general><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>H8D</scope><scope>L7M</scope><orcidid>https://orcid.org/0000-0003-1569-7288</orcidid></search><sort><creationdate>20200106</creationdate><title>Actively controlled local drug delivery using conductive polymer-based devices</title><author>Chapman, Christopher A. R. ; Cuttaz, Estelle A. ; Goding, Josef A. ; Green, Rylie A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-87ee1938bf7b26373bb0ccc81bc2107cca6fb3eb5ae5401bc05f6b405852ebd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Actuation</topic><topic>Applied physics</topic><topic>Bioavailability</topic><topic>Bioelectricity</topic><topic>Composite materials</topic><topic>Conducting polymers</topic><topic>Drug delivery systems</topic><topic>Drugs</topic><topic>Ion pumps</topic><topic>New technology</topic><topic>Properties (attributes)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chapman, Christopher A. R.</creatorcontrib><creatorcontrib>Cuttaz, Estelle A.</creatorcontrib><creatorcontrib>Goding, Josef A.</creatorcontrib><creatorcontrib>Green, Rylie A.</creatorcontrib><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Aerospace Database</collection><collection>Advanced Technologies Database with Aerospace</collection><jtitle>Applied physics letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chapman, Christopher A. R.</au><au>Cuttaz, Estelle A.</au><au>Goding, Josef A.</au><au>Green, Rylie A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Actively controlled local drug delivery using conductive polymer-based devices</atitle><jtitle>Applied physics letters</jtitle><date>2020-01-06</date><risdate>2020</risdate><volume>116</volume><issue>1</issue><issn>0003-6951</issn><eissn>1077-3118</eissn><coden>APPLAB</coden><abstract>Localized and actively controlled delivery of drugs presents an opportunity for improving bioavailability, therapeutic efficacy, and long-term treatment of injury or disease. Conductive polymer (CP) based systems present a unique opportunity for using inherent electrochemical and actuating properties to ensure that drugs are delivered or retained using charge controlled mechanisms. A number of CP formats have been explored spanning CP films, composites of CPs with polymeric carriers, and organic electronic ion pumps (OEIPs). Each of these designs can be used to deliver drugs with ionic properties that take advantage of the doping and dedoping characteristics of CPs during electrical pulsing or cycling. However, CP composites that use actuation and OEIPs are emerging technologies that can better address the need for the delivery of a wide range of drugs with varying net charge properties. These systems also allow a high drug loading profile, and with an appropriate configuration, they can use additional electrodes to drive drugs into the tissues. There are also innovative opportunities in the delivery of multiple drug types with varying charge properties that can be individually addressed. The future of CP based drug delivery systems will be strongly influenced by translational challenges including the need for regulatory approvals prior to the use of these novel material platforms in the clinic. Multidisciplinary collaboration will be critical to driving technology development and creating a new paradigm in personalized bioelectronic delivery of therapeutics.</abstract><cop>Melville</cop><pub>American Institute of Physics</pub><doi>10.1063/1.5138587</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-1569-7288</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-6951
ispartof Applied physics letters, 2020-01, Vol.116 (1)
issn 0003-6951
1077-3118
language eng
recordid cdi_scitation_primary_10_1063_1_5138587
source American Institute of Physics (AIP) Journals; Alma/SFX Local Collection
subjects Actuation
Applied physics
Bioavailability
Bioelectricity
Composite materials
Conducting polymers
Drug delivery systems
Drugs
Ion pumps
New technology
Properties (attributes)
title Actively controlled local drug delivery using conductive polymer-based devices
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T06%3A30%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_scita&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Actively%20controlled%20local%20drug%20delivery%20using%20conductive%20polymer-based%20devices&rft.jtitle=Applied%20physics%20letters&rft.au=Chapman,%20Christopher%20A.%20R.&rft.date=2020-01-06&rft.volume=116&rft.issue=1&rft.issn=0003-6951&rft.eissn=1077-3118&rft.coden=APPLAB&rft_id=info:doi/10.1063/1.5138587&rft_dat=%3Cproquest_scita%3E2332209286%3C/proquest_scita%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2332209286&rft_id=info:pmid/&rfr_iscdi=true